Analysis of the influence of proteolytic cleavage on the structural organization of the surface of the West Nile flavivirus leads to the isolation of a protease-resistant E protein oligomer from the viral surface.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 3629975)

Published in Virology on September 01, 1987

Authors

G Wengler, G Wengler, T Nowak, K Wahn

Articles by these authors

The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65

Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24

The carboxy-terminal part of the NS 3 protein of the West Nile flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase. Virology (1991) 2.75

Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins. Virology (1986) 2.75

Analyses of the terminal sequences of West Nile virus structural proteins and of the in vitro translation of these proteins allow the proposal of a complete scheme of the proteolytic cleavages involved in their synthesis. Virology (1989) 2.53

Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure (1996) 2.46

Spinach leaf phosphoenolpyruvate carboxylase: purification, properties, and kinetic studies. Arch Biochem Biophys (1974) 2.46

Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol (1989) 2.38

The NS 3 nonstructural protein of flaviviruses contains an RNA triphosphatase activity. Virology (1993) 2.12

Replicative form of Semliki Forest virus RNA contains an unpaired guanosine. Nature (1979) 2.09

Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence for these proteins. Virology (1985) 2.07

Studies on virus-specific nucleic acids synthesized in vertebrate and mosquito cells infected with flaviviruses. Virology (1978) 2.06

The allosteric regulation of pyruvate kinase by fructose-1,6-bisphosphate. Structure (1998) 2.02

The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97

Fusion between cell membrane and liposomes containing the glycoproteins of influenza virus. Virology (1980) 1.73

Sequence analysis of the membrane protein V3 of the flavivirus West Nile virus and of its gene. Virology (1985) 1.72

Structure of Semliki Forest virus core protein. Proteins (1997) 1.70

Analysis of disulfides present in the membrane proteins of the West Nile flavivirus. Virology (1987) 1.63

The core protein of the alphavirus Sindbis virus assembles into core-like nucleoproteins with the viral genome RNA and with other single-stranded nucleic acids in vitro. Virology (1982) 1.57

Analysis of structural properties which possibly are characteristic for the 3'-terminal sequence of the genome RNA of flaviviruses. J Gen Virol (1986) 1.52

Refined structure of Sindbis virus core protein and comparison with other chymotrypsin-like serine proteinase structures. J Mol Biol (1993) 1.49

Endovascular abdominal aneurysm repair: trends in Germany. Vasa (2012) 1.45

Identification of a sequence element in the alphavirus core protein which mediates interaction of cores with ribosomes and the disassembly of cores. Virology (1992) 1.44

Establishment and analysis of a system which allows assembly and disassembly of alphavirus core-like particles under physiological conditions in vitro. Virology (1984) 1.43

An infectious clone of the West Nile flavivirus. Virology (2001) 1.42

Trends in lower extremity surgical and endovascular revascularization in Germany. Vasa (2011) 1.41

Description of a procedure which allows isolation of viral nonstructural proteins from BHK vertebrate cells infected with the West Nile flavivirus in a state which allows their direct chemical characterization. Virology (1990) 1.34

Identification of a transfer of viral core protein to cellular ribosomes during the early stages of alphavirus infection. Virology (1984) 1.29

Terminal sequences of the genome and replicative-from RNA of the flavivirus West Nile virus: absence of poly(A) and possible role in RNA replication. Virology (1981) 1.25

Localization of the 26-S RNA sequence on the viral genome type 42-S RNA isolated from SFV-infected cells. Virology (1976) 1.23

Primary structures of the core proteins of the alphaviruses Semliki Forest virus and Sindbis virus. Virology (1981) 1.22

Medium hypertonicity and polyribosome structure in Hela cells. The influence of hypertonicity of the growth medium on polyribosomes in Hela cells. Eur J Biochem (1972) 1.21

The mode of assembly of alphavirus cores implies a mechanism for the disassembly of the cores in the early stages of infection. Brief review. Arch Virol (1987) 1.21

Morphological and physiological investigations on the action of polymyxin B on Escherichia coli. Arch Mikrobiol (1968) 1.19

Partial amino acid sequences of Sindbis and Semliki Forest virus-specific core proteins. Virology (1980) 1.17

Structural analysis of Sindbis virus capsid mutants involving assembly and catalysis. J Mol Biol (1996) 1.16

Analyses of the role of structural changes in the regulation of uncoating and assembly of alphavirus cores. Virology (1996) 1.15

Identification of an RNA-stimulated NTPase in the predicted helicase sequence of the Rubella virus nonstructural polyprotein. Virology (1996) 1.13

Isolated HE-protein from hemagglutinating encephalomyelitis virus and bovine coronavirus has receptor-destroying and receptor-binding activity. Virology (1991) 1.12

Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study. Neurogastroenterol Motil (2010) 1.10

Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. Virology (1991) 1.07

Association of the envelope glycoproteins of influenza virus with liposomes--a model study on viral envelope assembly. Virology (1979) 1.07

Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas. Front Med Biol Eng (1997) 1.06

Discovery of three novel orphan G-protein-coupled receptors. Genomics (1999) 1.06

Nuclear magnetic resonance studies of the function of potassium in the mechanism of pyruvate kinase. Biochemistry (1972) 1.05

Translation of 26 S virus-specific RNA from Semliki Forest virus-infected cells in vitro. Virology (1974) 1.05

In vitro translation of 42 S virus-specific RNA from cells infected with the flavivirus West Nile virus. Virology (1979) 1.05

Metal ion specificity at the catalytic site of yeast enolase. Biochemistry (1992) 1.01

Spontaneous volleys of bizarre high frequency potentials (b.h.f.p.) in neuro-muscular diseases. Part 1. Occurrence of spontaneous volleys of b.h.f.p. in neuro-muscular diseases. Electromyogr Clin Neurophysiol (1975) 1.00

The role of cations in avian liver phosphoenolpyruvate carboxykinase catalysis. Activation and regulation. J Biol Chem (1981) 1.00

Studies on the synthesis of viral RNA-polymerase-template complexes in BHK 21 cells infected with Semliki Forest virus. Virology (1975) 0.99

Nuclear relaxation and kinetic studies of the role of Mn 2+ in the mechanism of enolase. Biochemistry (1973) 0.96

Analysis of virus-specific RNA species and proteins in Freon-113 preparations of the Borna disease virus. Med Microbiol Immunol (1993) 0.96

Metal-ion-mediated allosteric triggering of yeast pyruvate kinase. 2. A multidimensional thermodynamic linked-function analysis. Biochemistry (1997) 0.95

Investigations of prion and virus safety of a new liquid IVIG product. Biologicals (2008) 0.93

Phosphoenolpyruvate carboxykinase. Mn2+ and Mn2+ substrate complexes. J Biol Chem (1982) 0.92

Studies on the polyribosome-associated RNA in BHK21 cells infected with Semliki Forest virus. Virology (1974) 0.91

Monomethylammonium ion as a magnetic resonance probe for monovalent cation activators. The monovalent cation in pyruvate kinase catalysis. J Biol Chem (1973) 0.90

Amino acid compositions and amino-terminal sequences of the structural proteins of a flavivirus, European Tick-Borne Encephalitis virus. Virology (1983) 0.90

Stereoselective interactions of phosphoenolpyruvate analogues with phosphoenolpyruvate-utilizing enzymes. J Biol Chem (1970) 0.90

Pyruvate kinase: activation by and catalytic role of the monovalent and divalent cations. Mol Cell Biochem (1981) 0.89

Kinetic evidence for a dual cation role for muscle pyruvate kinase. Arch Biochem Biophys (1982) 0.89

Plasmids of Staphylococcus cohnii isolated from the intensive-care unit. Folia Microbiol (Praha) (2004) 0.88

Protein synthesis in BHK-21 cells infected with semliki forest virus. J Virol (1975) 0.88

Purification and characterization of phosphoenolpyruvate carboxykinase from the parasitic helminth Ascaris suum. J Biol Chem (1986) 0.88

The purification, characterization, and activation of phosphoenolpyruvate carboxykinase from chicken liver mitochondria. J Biol Chem (1982) 0.88

Comparative studies on polyribosomal, nonpolyribosome-associated and viral 42 S RNA from BHK 21 cells infected with Semliki Forest virus. Virology (1975) 0.88

The isolation of the ectodomain of the alphavirus E1 protein as a soluble hemagglutinin and its crystallization. Virology (1999) 0.87

Terminal sequences of Sindbis virus-specific nucleic acids: identity in molecules synthesized in vertebrate and insect cells and characteristic properties of the replicative form RNA. Virology (1982) 0.87

Metal-ion-mediated allosteric triggering of yeast pyruvate kinase. 1. A multidimensional kinetic linked-function analysis. Biochemistry (1997) 0.86

Nuclear magnetic resonance studies of selectively hindered internal motion of substrate analogs at the active site of pyruvate kinase. Biochemistry (1972) 0.86

Transmission of HCV infection among long-term hospitalized onco-haematological patients. J Hosp Infect (2003) 0.86

Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis. Neurogastroenterol Motil (2013) 0.86

A histidine residue at the active site of avian liver phosphoenolpyruvate carboxykinase. J Biol Chem (1989) 0.85

Fluoride inhibition of yeast enolase. 2. Structural and kinetic properties of the ligand complexes determined by nuclear relaxation rate studies. Biochemistry (1981) 0.84